ukpurineclub.org
UK Purine Club-Meetings
http://www.ukpurineclub.org/UKPC_meetings.htm
Tilton and Swithland Suite at the University’s John Foster Hall, University of Leicester. Thursday 17th September 2015. Registration and abstract submision is STILL OPEN! However, we can no longer guarantee accomodation - so please email us. To confirm your needs and what we can arrange for you. We will also still accept abstracts for poster presentations only. Programme to include talks by:. Registration Full ( 40, g. Parking and accommodation ( 39 per night B&B) are available at John Foster Hall.
sarissa-diagnostics.com
SMARTChip | Sarissa Diagnostics
http://sarissa-diagnostics.com/smartchip
Each 15 minute decrease in treatment delay gained the. Of one month of additional disability-free life. Meretoja (2014) Stroke 45:1053-1058. Currently in final clinical trial we expect to launch a CE marked product in early 2017. Clinical trials funded through the i4i Programme in collaboration with UNCW and UHNM. SMARTChip is ideal for use with paramedics and within the Hyper Acute Stroke Units to shorten scene to needle time by helping to:. Speed diagnosis (time to identification). P: 44 (0)870 961 9991.
sarissa-diagnostics.com
Team | Sarissa Diagnostics
http://sarissa-diagnostics.com/team
Everard is an experienced commercial manager, having built 2 start-ups from concept through to revenue, managed product development programmes and been a VC investment executive. Everard has also advised SME and multi-nationals on strategy, commercialising R&D, IPOs and M&A transactions and is an NXD on VC backed ventures. Faming specalises in electrochemistry and leads the development of Sarissa’s sensor technology, he has also project managed Sarissa’s clinical trial. P: 44 (0)870 961 9991.
sarissa-diagnostics.com
News | Sarissa Diagnostics
http://sarissa-diagnostics.com/news
Sarissa’s stroke diagnostic: SMARTChip, wins SBRI grant award. Jul 4, 2016. Sarissa Biomedical Ltd together with its partners, the Oxford Academic Health Science Network, Newcastle University’s Stroke Research Group, Northumbria University and Coventry University’s HDTI, is pleased to report that it has been awarded 150,000 Phase 1 grant. read more. Sarissa Biomedical Ltd wins place at UK’s largest innovation show. Nov 2, 2015. Part of the Sarissa Biomedical Group. P: 44 (0)870 961 9991.
sarissa-diagnostics.com
Board | Sarissa Diagnostics
http://sarissa-diagnostics.com/board
Gary is a highly successful mid-cap private equity executive with Board experience across a broad range of industries and stages of development. A business angel and investor in Sarissa, Gary brings significant expertise and experience to support the management team. Quentin is currently CEO of Warwick Ventures and Director of several Warwick spin-outs. Prior to Warwick, he helped establish and led a number of early-stage technology companies operating in a wide range of sectors. Founder’s Director and a...
whistonbrook.co.uk
Whistonbrook - Sarissa Collaboration
http://whistonbrook.co.uk/Whistonbrook-Sarissa.htm
Experts in electrochemical equipment'. Collaboration with Sarissa Biomedical Limited. Whistonbrook Technologies have been collaborating with Sarissa Biomedical Limited on a number of medical diagnostic instrument projects over the past few years. Whistonbrook Technologies have developed two electrochemical diagnostic instrument system for Sarissa sensors. The first developed at the end of 2013 is a dual very low current analogue potentiostat for use with the Sarissaprobe. SMARTcap from Sarissa Biomedical.
sarissa-diagnostics.com
Biomarker | Sarissa Diagnostics
http://sarissa-diagnostics.com/biomarker
Purines are potentially a highly effective biomarker of stroke as they are released at the very onset of a stroke. Stroke is a higly complex condition, clinicians need to be confident in their diagnosis as treatment is not without risk. A clinically useful point of care test for stroke requires measurement of a rapidly produced biomarker to inform clinical decisions in the key early stages, where it would be most useful in ensuring complete recovery. Part of the Sarissa Biomedical Group.
sarissa-diagnostics.com
Problem | Sarissa Diagnostics
http://sarissa-diagnostics.com/problem
For patients experiencing acute. Saver (2006) Stroke 37:263-266. Ischaemic stroke (85% of all strokes) occurs when a blood vessel to the brain is blocked, cutting of blood circulation to that part of the brain, resulting in a deteriorating loss of neurological function. Rapid diagnosis is key, regrettably this is not achievable with current technology. Every minute during an ischemic stroke the brain loses:. Miles of Nerve Fibres. Saver (2006) Time is Brain. Stroke 37:263-266. Age and Ageing 38:27-32.
sarissa-diagnostics.com
Company | Sarissa Diagnostics
http://sarissa-diagnostics.com/company
Sarissa Biomedical was spun out from the University of Warwick to commercialise pioneering biosensor technologies developed by Professor Nick Dale. Its patented technology delivers a step change in enzymatic biosensor sensitivity and selectivity to detect and measure biomarkers in finger-prick blood sample within minutes, using low cost, single use biosensors and handheld readers. Sarissa is targeting the PoC. Part of the Sarissa Biomedical Group. P: 44 (0)870 961 9991. F: 44 (0)24 7601 0313.
SOCIAL ENGAGEMENT